{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Inventors", "item": "https://www.patentleaderboard.com/2021/inventors"}, {"@type": "ListItem", "position": 4, "name": "Eric Jon Jacobsen", "item": "https://www.patentleaderboard.com/2021/inventor/fl:er_ln:jacobsen-4"}]}

Home › 2021 › Inventors › Eric Jon Jacobsen

Eric Jon Jacobsen — 2 Patents in 2021

ATAclaris Therapeutics: 1 patents #1 of 4Top 25%

Chesterfield, MO: #81 of 754 inventorsTop 15%

Missouri: #277 of 2,600 inventorsTop 15%

Overall (2021): #163,933 of 548,734Top 30%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11021482	Pyrrolopyrimidine ITK inhibitors	David R. Anderson, James Robert Blinn, Susan L. Hockerman, Richard Heier, Paramita Mukherjee	2021-06-01
10981906	Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same	David R. Anderson, Susan L. Hockerman, James Robert Blinn	2021-04-20	$77,130,000

Eric Jon Jacobsen — 2 Patents in 2021

Issued Patents 2021

Patent Widget